Measuring glycated proteins: clinical and methodological aspects.

The recognition that nonenzymatic glycation, wherein free sugar condenses with certain reactive protein amino groups, is increased in hyperglycemic states has led to improved means for assessing diabetic control through the measurement of concentrations of glycated proteins in the circulation. This article reviews the chemistry, methods for measurement, and clinical relevance of circulating glycated proteins in the management of diabetes.

[1]  W. G. John,et al.  Enzyme immunoassay--a new technique for estimating hemoglobin A1c. , 1993, Clinical chemistry.

[2]  E. Schleicher,et al.  Is serum fructosamine assay specific for determination of glycated serum protein? , 1988, Clinical chemistry.

[3]  A. Smith,et al.  Comparison of Fructosamine With Glycosylated Hemoglobin and Plasma Proteins as Measures of Glycemic Control , 1988, Diabetes Care.

[4]  P. Metcalf,et al.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[5]  D. Nathan.  Hemoglobin Alc--infatuation or the real thing? , 1990, The New England journal of medicine.

[6]  J. Thijssen,et al.  A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[7]  R. Comtois,et al.  Clinical usefulness of estimation of serum fructosamine concentration as screening test for gestational diabetes , 1989, American journal of obstetrics and gynecology.

[8]  M. P. Cohen,et al.  Glycated LDL Concentrations in Non-Diabetic and Diabetic Subjects Measured with Monoclonal Antibodies Reactive with Glycated Apolipoprotein B Epitopes , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[9]  D. Goldstein,et al.  Glycated hemoglobin: methodologies and clinical applications. , 1986, Clinical chemistry.

[10]  M. Hørder,et al.  Analytical goal setting prior to selection of a method for glycated haemoglobin. , 1990, Scandinavian journal of clinical and laboratory investigation.

[11]  J. Cohen,et al.  Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system. , 1998, Kidney international.

[12]  P. Reichard,et al.  The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. , 2009, Acta medica Scandinavica.

[13]  R. Comtois,et al.  Clinical usefulness of estimation of serum fructosamine concentration as screening test for gestational diabetes. , 1989 .

[14]  R Shapiro,et al.  Sites of nonenzymatic glycosylation of human hemoglobin A. , 1980, The Journal of biological chemistry.

[15]  K. Beach.  A theoretical model to predict the behavior of glycosylated hemoglobin levels. , 1979, Journal of theoretical biology.

[16]  T. M. Hayes,et al.  Glycosylated Serum Albumin: An Intermediate Index of Diabetic Control , 1983, Diabetes Care.

[17]  E. Eschwège,et al.  Comparison of glycosylated hemoglobin and fasting plasma glucose with two-hour post-load plasma glucose in the detection of diabetes mellitus. , 1985, American journal of epidemiology.

[18]  D. Goldstein,et al.  Standardization of glycohemoglobin determinations in the clinical laboratory: three years of experience. , 1992, Clinical chemistry.

[19]  J. Pickup,et al.  Blood Glucose and Glycated Haemoglobin Measurement in Hospital: Which Method? , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[20]  E. Schleicher,et al.  Kinetic analysis of glycation as a tool for assessing the half-life of proteins. , 1986, Biochimica et biophysica acta.

[21]  J. Baynes,et al.  Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Baynes,et al.  Nonenzymatic Glucosylation of Serum Proteins and Hemoglobin: Response to Changes in Blood Glucose Levels in Diabetic Rats , 1980, Diabetes.

[23]  M. Davidson,et al.  The role of glucosylated serum albumin in monitoring glycemic control in stable insulin-requiring diabetic out-patients. , 1987, The Journal of clinical endocrinology and metabolism.

[24]  T. Utsugi,et al.  Age-Related Alteration of Pancreatic β-cell Function: Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance , 1996, Diabetes Care.

[25]  L. Morin,et al.  Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. , 1987, Clinical chemistry.

[26]  V. Salomaa,et al.  Impact of Diabetes on Mortality After the First Myocardial Infarction , 1998, Diabetes Care.

[27]  J. Marples,et al.  Simple colorimetry of glycated serum protein in a centrifugal analyzer. , 1984, Clinical chemistry.

[28]  K. Miedema,et al.  Candidate reference methods for hemoglobin A1c based on peptide mapping. , 1997, Clinical chemistry.

[29]  Vickie,et al.  Interlaboratory standardization of measurements of glycohemoglobins. , 1992, Clinical chemistry.

[30]  D. Goldstein,et al.  Affinity binding assay of glycohemoglobin by two-dimensional centrifugation referenced to hemoglobin A1c. , 1992, Clinical chemistry.

[31]  J. Malone,et al.  Hemoglobin South Florida: New Variant With Normal Electrophoretic Pattern Mistaken for Glycosylated Hemoglobin , 1986, Diabetes.

[32]  J. Hautvast,et al.  Multiple overnight urine collections may be used for estimating the excretion of electrolytes and creatinine. , 1988, Clinical chemistry.

[33]  Cohen Mp.  Perspective: measurement of circulating glycated proteins to monitor intermediate-term changes in glycaemic control. , 1992 .

[34]  J. Birke,et al.  Evaluation of a Self-Administered Sensory Testing Tool to Identify Patients at Risk of Diabetes-Related Foot Problems , 1998, Diabetes Care.

[35]  H. Ueno,et al.  Some factors that influence the nonenzymatic glycation of peptides and polypeptides by glyceraldehyde , 1989, Journal of protein chemistry.

[36]  T. Huisman,et al.  A new high-performance liquid chromatographic procedure to quantitate hemoglobin A1c and other minor hemoglobins in blood of normal, diabetic, and alcoholic individuals. , 1983, The Journal of laboratory and clinical medicine.

[37]  C. Lunan,et al.  Glycosylated albumin and glycosylated proteins: rapidly changing indices of glycaemia in diabetic pregnancy. , 1985, The Quarterly journal of medicine.

[38]  R. Flückiger,et al.  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. , 1986, The Journal of biological chemistry.

[39]  J. Jeppsson,et al.  Clinical utility of serum fructosamine in diabetes mellitus compared with hemoglobin A1c. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[40]  S. Taş,et al.  Automated fructosamine assay with improved accuracy used to quantify nonenzymatic glycation of serum proteins in diabetes mellitus and chronic renal failure. , 1990, Clinical chemistry.

[41]  P. K. Smith,et al.  Clinical Use and Time Relationship of Changes in Affinity Measurement of Glycosylated Albumin and Glycosylated Hemoglobin , 1986, The American journal of the medical sciences.

[42]  D. Bhatnagar,et al.  An Analysis of Glycosylated Blood Proteins and Blood Glucose Profiles Over One Year in Patients with Type 1 Diabetes , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[43]  P. Reichard,et al.  Nephropathy is delayed by intensified insulin treatment in patients with insulin‐dependent diabetes mellitus and retinopathy * , 1989, Journal of internal medicine.

[44]  K. Shima,et al.  The Response of GHb to Stepwise Plasma Glucose Change Over Time in Diabetic Patients , 1993, Diabetes Care.

[45]  S. Kemp,et al.  Glycosylated albumin and transferrin: short-term markers of blood glucose control. , 1984, The Journal of pediatrics.

[46]  O. Platt,et al.  Glycosylation of Variant Hemoglobins in Normal and Diabetic Subjects , 1980, Diabetes Care.

[47]  A. Acharya,et al.  Aldimine to ketoamine isomerization (Amadori rearrangement) potential at the individual nonenzymic glycation sites of hemoglobin a: Preferential inhibition of glycation by nucleophiles at sites of low isomerization potential , 1991, Journal of protein chemistry.

[48]  S Tomita,et al.  Measurement of glycated albumin by the nitroblue tetrazolium colorimetric method. , 1992, Clinica chimica acta; international journal of clinical chemistry.

[49]  Y. Lim,et al.  Measurement of plasma fructosamine evaluated for monitoring diabetes. , 1985, Clinical chemistry.

[50]  R. Turner,et al.  Glycosylated Plasma Protein Measurement by a Semi-Automated Method , 1986, Annals of clinical biochemistry.

[51]  Clark Cm,et al.  Prevention and Treatment of the Complications of Diabetes Mellitus , 1995 .

[52]  David C. Klonoff,et al.  Analysis: Serum Fructosamine as a Screening Test for Type 2 Diabetes , 2000 .

[53]  K. Shima,et al.  High-performance affinity chromatography system for the rapid, efficient assay of glycated albumin. , 1992, Journal of chromatography.

[54]  J. Baynes,et al.  Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. , 1979, The Journal of biological chemistry.

[55]  P. Winocour,et al.  Relative Clinical Usefulness of Glycosylated Serum Albumin and Fructosamine During Short-Term Changes In Glycemic Control in IDDM , 1989, Diabetes Care.

[56]  D. Singer,et al.  The clinical information value of the glycosylated hemoglobin assay. , 1984, The New England journal of medicine.

[57]  O. Wieland,et al.  Increased Glycosylation of Serum Albumin in Diabetes Mellitus , 1980, Diabetes.

[58]  J. Joven,et al.  Semiautomated determination of glycated albumin in glycaemic control of diabetic patients. , 1994, Clinical biochemistry.

[59]  P. Winocour,et al.  A comparison of direct measures of glycaemia and glycated blood proteins in insulin-dependent diabetes mellitus. , 1989, Clinical biochemistry.

[60]  P. Reichard,et al.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.

[61]  C. Jackson,et al.  Four assay methods for glycated hemoglobin compared as screening tests for diabetes mellitus: the Islington Diabetes Survey. , 1988, Clinical chemistry.

[62]  P. Reichard,et al.  Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS) , 1990, Journal of internal medicine.

[63]  D A Armbruster,et al.  Fructosamine: structure, analysis, and clinical usefulness. , 1987, Clinical chemistry.

[64]  A. Hanlon,et al.  Longitudinal changes in serum fructosamine do not parallel those in glycated haemoglobin in young adults with insulin-dependent diabetes. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[65]  M. Itakura,et al.  Limited synthesis of labile hemoglobin A1 in vivo and in vitro by the preexisting hemoglobin A1 in diabetic subjects. , 1986, Endocrinologia japonica.

[66]  R. Shapiro,et al.  Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. , 1978, The Journal of biological chemistry.

[67]  R. Hanson,et al.  Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes , 1994, BMJ.

[68]  I. Laing,et al.  Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects. , 1992, Atherosclerosis.

[69]  A. Krolewski,et al.  Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[70]  W. Cefalu,et al.  Validity of Serum Fructosamine as Index of Short-Term Glycemic Control in Diabetic Outpatients , 1988, Diabetes Care.

[71]  N. Fineberg,et al.  Immediate HbA1c Results: Performance of new HbA1c system in pediatric outpatient population , 1992, Diabetes Care.

[72]  M. Cohen,et al.  Immunologic detection and measurement of glycated apolipoprotein B with site specific monoclonal antibodies. , 1993, Journal of immunological methods.

[73]  D. Bruns.  Standardization, calibration, and the care of diabetic patients. , 1992, Clinical chemistry.

[74]  E. Diamandis,et al.  An automated "high-pressure" liquid-chromatographic assay for hemoglobin A1c. , 1984, Clinical chemistry.

[75]  K. Miedema,et al.  Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations. , 1996, Journal of the International Federation of Clinical Chemistry.

[76]  F N Ziyadeh,et al.  Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. , 1995, The Journal of clinical investigation.

[77]  P. Gallop,et al.  The glycosylation of hemoglobin: relevance to diabetes mellitus. , 1978, Science.

[78]  J. Windeler,et al.  The fructosamine assay in diagnosis and control of diabetes mellitus scientific evidence for its clinical usefulness? , 1990, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[79]  T. Huisman,et al.  A new high-performance liquid chromatographic procedure for the separation and quantitation of various hemoglobin variants in adults and newborn babies. , 1983, The Journal of laboratory and clinical medicine.

[80]  P. Reichard,et al.  Intensified conventional insulin treatment retards the microvascular complications of insulin‐dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years , 1991, Journal of internal medicine.

[81]  H. Mortensen,et al.  Hemoglobin Hafnia: α2(β116 (G18) His→Gln)2: a new hemoglobin variant mistaken for glycated hemoglobin , 1988 .

[82]  E. Shultz,et al.  Glycosylated serum proteins and glycosylated hemoglobin in the assessment of glycemic control in insulin-dependent and non-insulin-dependent diabetes mellitus. , 1993, Metabolism: clinical and experimental.

[83]  R. Clements,et al.  Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. , 1998, Journal of diabetes and its complications.

[84]  R. Moses,et al.  Improved estimation of fructosamine, as a measure of glycated serum protein, with the Technicon RA-1000 analyzer. , 1985, Clinical chemistry.

[85]  Y. Ohe,et al.  Radioimmunoassay of glycosylated albumin with monoclonal antibody to glucitol-lysine. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[86]  T. Hasegawa,et al.  Receiver Operating Characteristic Analysis on Fasting Plasma Glucose, HbA1c, and Fructosamine on Diabetes Screening , 1991, Diabetes Care.

[87]  A. Carpinelli,et al.  Evaluation of a new semi-automated high-performance liquid chromatography method for glycosylated haemoglobins , 1986, The Journal of automatic chemistry.

[88]  T. Pieber,et al.  Automated determination of glycated hemoglobin: Comparative evaluation of five assay systems , 1994, Journal of clinical laboratory analysis.

[89]  R. Garlick,et al.  The principal site of nonenzymatic glycosylation of human serum albumin in vivo. , 1983, The Journal of biological chemistry.

[90]  P. Higgins,et al.  Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins. , 1983, The Journal of clinical investigation.

[91]  R. Shapiro,et al.  Structural analysis of the minor human hemoglobin components: Hb AIa1, Hb AIa2 and Hb AIb. , 1980, European journal of biochemistry.

[92]  P. Chanson,et al.  Comparison of HbA1 and Fructosamine in Diagnosis of Glucose-Tolerance Abnormalities , 1990, Diabetes Care.

[93]  G. Viberti.  A glycemic threshold for diabetic complications? , 1995, The New England journal of medicine.

[94]  F. Nuttall.  Comparison of Percent Total GHb With Percent HbA1c in People With and Without Known Diabetes , 1998, Diabetes Care.

[95]  F. Engbaek,et al.  Interference of abnormal hemoglobins on the measurement of hemoglobin A1c by ion-exchange chromatography. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[96]  M. Cohen,et al.  Evaluation and performance characteristics of a novel ELISA using monoclonal antibody to glycated albumin. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[97]  M. Cohen,et al.  Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. , 1989, Journal of immunological methods.

[98]  J. Baker,et al.  Serum fructosamine: a screening test for diabetes in pregnancy. , 1986, American journal of obstetrics and gynecology.

[99]  K. Shima,et al.  The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus. , 1989, Diabetes research and clinical practice.

[100]  G. Schmid,et al.  Determination of glycated hemoglobin by affinity chromatography. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[101]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.